Loading...

HEREDITARY SPHEROCYTOSIS GENE PANEL BY NGS, EDTA BLOOD

image not found

 NABL Cap Accredited 
The Hereditary Spherocytosis Gene Panel by NGS identifies genetic mutations responsible for hereditary spherocytosis, a red blood cell membrane disorder causing anemia and hemolysis. Using an EDTA blood sample, this test detects defects in membrane proteins that affect RBC shape and stability. Metropolis Healthcare uses advanced next-generation sequencing to ensure precise and comprehensive mutation analysis. The results support accurate diagnosis, treatment planning, and family risk assessment

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:G0207

Frequently Asked Questions (FAQ's):

What does the Hereditary Spherocytosis Gene Panel include at Metropolis Healthcare?
It analyzes key genes involved in red blood cell membrane formation using high-accuracy NGS technology.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from an EDTA blood sample and sequences targeted genes to identify pathogenic variants.

Who should consider this test at Metropolis Healthcare?
Individuals with unexplained hemolytic anemia, jaundice, enlarged spleen, or a family history of spherocytosis may benefit from this panel.

What sample is required for this test at Metropolis Healthcare?
A standard EDTA blood sample is used to obtain high-quality DNA for sequencing.

How long does Metropolis Healthcare take to deliver the report?
Results are provided within a standard genetic testing timeline after detailed analysis and expert review.

Why choose Metropolis Healthcare for this genetic panel?
Metropolis Healthcare ensures comprehensive gene coverage, accurate sequencing, and clinically meaningful interpretation.

Does Metropolis Healthcare offer post-test support?
Yes, the report includes expert insights to help clinicians guide treatment, monitoring, and family counseling.

Is this test suitable for pediatric patients at Metropolis Healthcare?

Yes, the test is appropriate for both children and adults with suspected hereditary spherocytosis 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab